Cacti / Mescaline - OPEN Foundation

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways

López-Giménez, J. F., & González-Maeso, J. | Current Topics in Behavioral Neuroscience | 5 July 2017

Humanistic Psychology, Psychedelics, and the Transpersonal Vision

Grob, C. S., & Bossis, A. | Journal of Humanistic Psychology | 1 July 2017

Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness

Forstmann, M., & Sagioglou, C. | Journal of Psychopharmacology | 1 June 2017

Peyote as Commodity: An Examination of Market Actors and Access Mechanisms

Feeney, K. | Human Organization | 1 March 2017

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 31 October 2016

Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Reemerging Treatment Paradigm

Hendricks, P. S., & Grob, C. S. | Rational Suicide in the Elderly | 29 October 2016

The Entheogen Reformation

Roberts, T. B. | Association for Transpersonal Psychology | 1 October 2016

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016

Anxiety Mescaline

Kyzar, E. J., Collins, C., Gaikwad, S., Green, J., Roth, A., Monnig, L., ... & Stewart, A. M.

Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents

Carlini, E. A., & Maia, L. O. | 9 November 2015

Psychedelic medicine: A re-emerging therapeutic paradigm

Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. | CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne | 08 September 2015

Psychedelics and creativity: a review of the quantitative literature

Baggott, M. J. | PeerJ PrePrints | 30 June 2015

A Note on the Docking of some Hallucinogens to the 5-HT2A Receptor

Gómez-Jeria, J. S., & Robles-Navarro, A. | Journal of Computational Methods in Molecular Design | April 2015

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., & Johnson, M. W. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 14 March 2015

Psychedelics not linked to mental health problems or suicidal behavior: A population study

Johansen, P. Ø., & Krebs, T. S. | Journal of Psychopharmacology | 5 March 2015

What Can Neuroscience Tell Us About the Potential of Psychedelics in Healthcare?

Mackenzie, R. | Current Drug Abuse Reviews | 23 February 2015

Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?

Majić, T., Schmidt, T. T., & Gallinat, J. | Journal of Psychopharmacology | 9 February 2015

Editorial (Thematic Issue: Introduction to ‘Beneficial Effects of Psychedelics with a Special Focus on Addictions’)

Kortekaas, R., & Breeksema, J. J. | Current Drug Abuse Reviews | 28 January 2015

Psychedelics as Medicines for Substance Abuse Rehabilitation: Evaluating Treatments with LSD, Peyote, Ibogaine and Ayahuasca

Winkelman, M. | Current Drug Abuse Reviews | 28 January 2015

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. | Journal of Psychopharmacology | 13 January 2015